Abaloparatide
Abaloparatide is a synthetic 34-amino-acid analogue of PTHrP (parathyroid hormone-related protein) approved in the US as Tymlos for osteoporosis. activates PTH1R in the RG conformation, producing more anabolic bone effects than teriparatide.
Potency loss over time
Estimated potency retained (%) per storage condition. Hover the chart for details.
⚠ Computed from molecular properties (sequence length, cyclisation, residues prone to oxidation or deamidation, light sensitivity), per compound. Indicative only — not lab-measured per batch.
Time in body
How much of a single dose remains over time, modelled from the terminal half-life. Illustrative — not a dosing tool.
Half-life ~1.7 h (human PK) · effectively cleared (~97%) after ~8.5 h (5 half-lives).
Research context only — not dosing guidance. · Source: FDA Tymlos label (~1.7 h)
| # | Suppliers | Price | €/mg | Price trend (6 months) | Purity | COA | Score ⓘ | |
|---|---|---|---|---|---|---|---|---|
| 1 |
 24P
| €69 | €23.0/mg | ▼1.7% | 99% | ✔ Liquilabs | Shop → |
Prices manually checked and updated monthly — source: publicly available supplier data. No affiliate links, no paid placement.
Abaloparatide
Mechanism, evidence level, EU status and COA guidance per compound. No dosages, no protocols — that belongs with a doctor.